Newly Approved Drug Therapies (390): Timentin, SmithKline Beecham

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Timentin

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: SmithKline Beecham
Approval Status: Approved January 1998
Treatment for: Infections in children

General Information

Timentin (disodium/clavulanate potassium) has been approved as an injectable antibiotic for use in treating a wide range of infections in children aged 3 months to 16 years. The drug was previously approved for use in adult patients.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]